Related Experiment Video
Updated: Aug 11, 2026
Transplantation of Pulmonary Valve Using a Mouse Model of Heterotopic Heart Transplantation
Published on: July 23, 2014
Pediatric heart transplantation
1University of Colorado Health Sciences Center, Denver, USA.
Insights
Pediatric heart transplantation is increasingly successful, especially for infants with congenital heart disease. While early mortality remains highest in the first year of life, new strategies are improving outcomes for these high-risk patients.
Area of Science:
- Cardiology
- Pediatric Surgery
- Transplantation Medicine
Background:
- Congenital heart disease (CHD) is a leading cause of mortality in the first year of life.
- Pediatric heart transplantation has seen significant growth and success.
- The first year of life is the most common age for pediatric heart transplantation due to CHD.
Purpose of the Study:
- To review key advances in pediatric heart transplantation over the past year.
- To highlight the current status and challenges in treating infants with congenital heart disease requiring transplantation.
- To discuss emerging strategies for improving outcomes in high-risk pediatric heart transplant recipients.
Main Methods:
- Literature review of recent studies on pediatric heart transplantation.
- Analysis of survival data and risk factors in pediatric heart transplant recipients.
- Synthesis of information on new surgical and medical management techniques.
Main Results:
- Pediatric heart transplantation is a successful treatment for end-stage heart failure in children.
- Congenital heart disease is the primary indication for pediatric heart transplantation.
- Infants transplanted within the first year of life face the highest early mortality risk.
- New interventions are being developed to mitigate early mortality in high-risk infants.
- Long-term survival rates remain excellent with low morbidity.
Conclusions:
- Pediatric heart transplantation is a vital and evolving field.
- Ongoing research and clinical advancements are improving survival rates, particularly for the youngest and highest-risk patients.
- Continued focus on identifying at-risk populations and implementing novel strategies is crucial for further success.
Abstract:
Studies from a number of centers have documented the growth and success of pediatric heart transplantation. The 1st year of life is the period of greatest mortality from congenital heart disease and has now become the single most frequent age of pediatric heart transplantation. Appropriately, congenital heart disease is the most common diagnosis leading to heart transplantation. Early mortality is still greatest in recipients who undergo transplantation during the 1st year of life. The patients at greatest risk are being identified and new maneuvers to lower early mortality are emerging. Long-term follow-up continues to indicate excellent late survival with low morbidity. This review focuses on key advances in knowledge reported in the last year.
